Skip to main content
. 2023 Jul 24;80(9):910–918. doi: 10.1001/jamaneurol.2023.2303

Table 3. Pediatric Modified Rankin Scale (mRS) Scores at Final Available Follow-up.

Outcome No. (%) OR (95% CI) P valuea
Thrombectomy group (n = 26) Control group (n = 26)
Pediatric mRS score at final follow-up
0 7 (26.9) 1 (3.8) 3.65 (1.25-10.68) .02
1 2 (7.7) 3 (11.5)
2 13 (50.0) 11 (42.3)
3 3 (11.5) 9 (34.6)
4 0 1 (3.8)
5 0 0
6 1 (3.8) 1 (3.8)
0-2 22 (84.6) 15 (57.7) NA NA
3-6 4 (15.4) 11 (42.3) NA NA
PSOM score at final follow-up
0 7 (26.9) 1 (3.8) 4.33 (1.56-12.01) .005
0.5 2 (7.7) 3 (11.5)
1.0-2.5 13 (50.0) 11 (42.3)
3.0-5.0 3 (11.5) 9 (34.6)
6.0-7.0 0 1 (3.8)
8.0-9.0 0 0
10.0 1 (3.8) 1 (3.8)
Timing of final follow-up poststroke, mean (SD), mo 19.7 (15.7) 46.4 (29.0) NA <.001
Secondary safety outcomes
Craniectomy 5 (19.2) 6 (23.1) NA .73
Major access site complicationsb 2 (7.7) 0 NA .15

Abbreviations: NA, not applicable; OR, odds ratio; PSOM, Pediatric Stroke Outcome Measure.

a

P values calculated using ordinal linear regression, χ2, or t tests, as appropriate.

b

Major access site complications were defined as a complication arising from the arterial access site requiring blood transfusion, surgery, or endovascular treatment. In the thrombectomy arm, 1 patient had a retroperitoneal hemorrhage requiring blood transfusion and placement of a covered stent. The second patient developed a delayed common femoral artery pseudoaneurysm while taking anticoagulation, successfully treated with percutaneous thrombin injection.